Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-25 Sale | 2026-03-26 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 3,844 | $21.47 | $82,531 | 33,827 (Direct) | View |
| 2026-02-09 Sale | 2026-02-10 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 6,950 | $23.38 | $162,491 | 20,554 (Direct) | View |
| 2021-12-14 Sale | 2021-12-15 4:06 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 451 | $2.4171 | $1,090 | 30,399 (Direct) | View |
| 2021-11-15 Sale | 2021-11-16 4:09 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 433 | $4.4 | $1,905 | 30,850 (Direct) | View |
| 2021-10-14 Sale | 2021-10-15 4:10 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 430 | $8.65 | $3,720 | 31,283 (Direct) | View |
| 2021-09-14 Sale | 2021-09-15 4:31 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 430 | $10.64 | $4,575 | 31,713 (Direct) | View |
| 2021-08-16 Sale | 2021-08-17 4:05 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 445 | $10.68 | $4,753 | 32,143 (Direct) | View |
| 2021-07-21 Sale | 2021-07-22 6:06 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 432 | $10.94 | $4,726 | 32,588 (Direct) | View |
| 2021-07-14 Sale | 2021-07-15 4:08 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 431 | $11.01 | $4,745 | 32,589 (Direct) | View |
| 2021-06-14 Sale | 2021-06-16 4:06 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 427 | $13.27 | $5,666 | 33,020 (Direct) | View |
| 2021-05-14 Sale | 2021-05-18 4:04 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 440 | $13.92 | $6,125 | 33,447 (Direct) | View |
| 2021-04-15 Sale | 2021-04-15 4:05 pm | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 399 | $15.01 | $5,989 | 33,887 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-24 Exercise | 2026-03-26 8:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 7,515 | $0 | 33,827 (Direct) | View |
| 2026-03-06 Option Award | 2026-03-10 6:00 pm | N/A 2036-03-05 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 117,073 | $0 | 117,073 (Direct) | View |
| 2026-02-06 Exercise | 2026-02-10 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 12,944 | $0 | 20,554 (Direct) | View |
| 2025-03-24 Option Award | 2025-03-26 8:03 pm | N/A 2035-03-23 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 132,351 | $0 | 133,371 (Direct) | View |
| 2024-02-06 Option Award | 2024-02-08 5:09 pm | N/A 2034-02-05 | ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 152,478 | $0 | 152,478 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 4:21 pm | N/A 2032-03-01 | Angion Biomedica Corp. | ANGN | Rhodes Jennifer J See Remarks | 275,000 | $0 | 450,000 (Direct) | View |